Contemporary optimized practice in the management of pulmonary sarcoidosis by Shambhu Aryal, Steven D. Nathan

Get full text

Clinical implications of six-minute walk test in patients with idiopathic pulmonary fibrosis: a retrospective cohort study by Min Jee Kim, Steven D. Nathan, Hyeon Hwa Kim, Ho Cheol Kim

Get full text

Healthcare resource utilization in patients with pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD): a real-world data analysis by Tracey Weiss, Aimee M. Near, Xiaohui Zhao, Dena Rosen Ramey, Tania Banerji, Handing Xie, Steven D. Nathan

Get full text

The 6-min walk test as a primary end-point in interstitial lung disease by Sergio Harari, Athol U. Wells, Wim A. Wuyts, Steven D. Nathan, Klaus-Uwe Kirchgaessler, Monica Bengus, Jürgen Behr

Get full text

Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Dev... by Steven D. Nathan, Peter Fernandes, Mitchell Psotka, Patrizio Vitulo, Lucilla Piccari, Katerina Antoniou, Sylvia M. Nikkho, Norman Stockbridge

Get full text

COPD associated pulmonary hypertension: A post hoc analysis of the PERFECT study by Steven D. Nathan, Victoria Lacasse, Heidi Bell, Prakash Sista, Michael Di Marino, Todd Bull, Victor Tapson, Aaron Waxman

Get full text

Impact of the new definition for pulmonary hypertension in patients with lung disease: an analysis of the United Network for Organ Sharing database by Steven D. Nathan, Scott D. Barnett, Christopher S. King, Steeve Provencher, Joan A. Barbera, Jean Pastre, Oksana A. Shlobin, Werner Seeger

Get full text

HRCT evaluation of patients with interstitial lung disease: comparison of the 2018 and 2011 diagnostic guidelines by Steven D. Nathan, Jean Pastre, Inga Ksovreli, Scott Barnett, Christopher King, Shambhu Aryal, Kareem Ahmad, Cesar Fukuda, Vijaya Ramalingam, Jonathan H. Chung

Get full text

Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Inn... by Oksana A. Shlobin, Eric Shen, Stephen J. Wort, Lucilla Piccari, John A. Scandurra, Paul M. Hassoun, Sylvia M. Nikkho, Steven D. Nathan

Get full text

Excess healthcare resource utilization and costs for commercially insured patients with pulmonary arterial hypertension: A real‐world data analysis by Tracey Weiss, Dena R. Ramey, Ngan Pham, Nazneen Fatima Shaikh, Dajun Tian, Xiaohui Zhao, Aimee M. Near, Dominik Lautsch, Steven D. Nathan

Get full text

Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis by Vincent Cottin, Steven D Nathan, Lisa Lancaster, Peter Smith, Kevin R Flaherty, Jürgen Behr, CQ Deng, Natalie Pearce, Heidi Bell, Leigh Peterson

Get full text

Prevalence of pulmonary hypertension in patients with COVID‐19 related lung disease listed for lung transplantation: A UNOS registry analysis by Christopher Thomas, Abhimanyu Chandel, Christopher S. King, Shambhu Aryal, A. Whitney Brown, Vikramjit Khangoora, Alan Nyquist, Anju Singhal, Onix Cantres Fonseca, Oksana Shlobin, Steven D. Nathan

Get full text

External validation and longitudinal application of the DO-GAP index to individualise survival prediction in idiopathic pulmonary fibrosis by Abhimanyu Chandel, Christopher S. King, Rosalinda V. Ignacio, Jean Pastre, Oksana A. Shlobin, Vikramjit Khangoora, Shambhu Aryal, Alan Nyquist, Anju Singhal, Kevin R. Flaherty, Steven D. Nathan

Get full text

Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real‐world patient data repository by Harrison W. Farber, Murali M. Chakinala, Michelle Cho, Robert P. Frantz, Andrew Frick, Lisa Lancaster, Scott Milligan, Ronald Oudiz, Sumeet Panjabi, Yuen Tsang, Steven D. Nathan

Get full text

A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease by Toby M. Maher, Courtney Schiffman, Michael Kreuter, Catharina C. Moor, Steven D. Nathan, Judit Axmann, Paula Belloni, Monica Bengus, Frank Gilberg, Klaus-Uwe Kirchgaessler, Marlies S. Wijsenbeek

Get full text

Incidence and prognostic significance of pleural effusions in pulmonary arterial hypertension by Abhimanyu Chandel, Alison Verster, Husna Rahim, Vikramjit Khangoora, Steven D. Nathan, Kareem Ahmad, Shambhu Aryal, Aaron Bagnola, Anju Singhal, A. Whitney Brown, Oksana A. Shlobin, Christopher S. King

Get full text

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Inst... by Lucilla Piccari, Brian Allwood, Katerina Antoniou, Jonathan H. Chung, Paul M. Hassoun, Sylvia M. Nikkho, Rajan Saggar, Oksana A. Shlobin, Patrizio Vitulo, Steven D. Nathan, Stephen John Wort

Get full text

Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis by Lisa H. Lancaster, Joao A. de Andrade, Joseph D. Zibrak, Maria L. Padilla, Carlo Albera, Steven D. Nathan, Marlies S. Wijsenbeek, John L. Stauffer, Klaus-Uwe Kirchgaessler, Ulrich Costabel

Get full text

Discrepancy between pulmonary arterial wedge pressure and left ventricular end diastolic pressure in patients with interstitial lung disease by Ho Cheol Kim, MD, Onix Cantres Fonseca, MD, Behnam N. Tehrani, MD, Christopher S. King, MD, Christopher Thomas, MD, Vikramjit Khangoora, MD, Oksana A. Shlobin, MD, Steven D. Nathan, MD

Get full text

Factors associated with listing for lung transplantation in IPF patients: An analysis of the pulmonary fibrosis foundation registry by Christopher S. King, Emily White, Shambhu Aryal, Oksana A. Shlobin, Anju Singhal, A. Whitney Brown, Christopher Thomas, Vikramjit Khangoora, Alan Nyquist, Kevin R. Flaherty, Steven D. Nathan, Joshua J. Mooney

Get full text